Rompost 500 Combipack Injection 1's belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.

Rompost 500 Combipack Injection 1's contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Rompost 500 Combipack Injection 1's promotes platelet formation by activating the thrombopoietin receptor. Thereby, Rompost 500 Combipack Injection 1's helps treat immune thrombocytopenia effectively.

Rompost 500 Combipack Injection 1's will be administered by the healthcare professional. In some cases, Rompost 500 Combipack Injection 1's may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Notify your doctor if you have allergic reactions to Rompost 500 Combipack Injection 1's or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Rompost 500 Combipack Injection 1's is not recommended during pregnancy unless indicated by the doctor. Rompost 500 Combipack Injection 1's may make you dizzy; hence drive or operate machinery only when you are alert. Rompost 500 Combipack Injection 1's is not recommended for use during breastfeeding.

Rompost 500 Combipack Injection 1's is used in the treatment of immune thrombocytopenia (an immune disorder characterised by low platelet counts). The detailed uses of Rompost 500 Combipack Injection 1's are as follows:

• Treats Immune Thrombocytopenia (ITP): Rompost 500 Combipack Injection 1's is primarily used in adults with chronic ITP and children with ITP lasting at least 6 months who have not responded adequately to treatments such as splenectomy (surgical removal of the spleen) or medications like corticosteroids and immunoglobulins.
• Reduces Bleeding Risk: Rompost 500 Combipack Injection 1's helps prevent bleeding episodes by increasing platelet production, particularly in patients with persistent or recurrent ITP.
• Serves as a Steroid-Sparing Agent: Rompost 500 Combipack Injection 1's may be used as an alternative to or in combination with corticosteroids to help reduce the need for long-term steroid treatment and minimise the risk of associated side effects in ITP patients.
• Manages Preoperative Thrombocytopenia: In certain cases, Rompost 500 Combipack Injection 1's may be administered before surgical procedures in patients with ITP to temporarily increase platelet counts and reduce bleeding risks.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Rompost 500 Combipack Injection 1's will be administered by a nurse or doctor.
• Do not self-administer.

Rompost 500 Combipack Injection 1's contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Rompost 500 Combipack Injection 1's promotes platelet formation by activating the thrombopoietin receptor. Thereby, Rompost 500 Combipack Injection 1's helps treat immune thrombocytopenia effectively.

Before beginning Rompost 500 Combipack Injection 1's, notify your doctor if you have had any allergic reactions to Rompost 500 Combipack Injection 1's or any other medications. You must notify your doctor if you have blood or bone marrow cancer (leukaemia), bleeding or clotting disorders, heart, kidney, or liver problems. Rompost 500 Combipack Injection 1's is not recommended during pregnancy unless indicated by the doctor. Rompost 500 Combipack Injection 1's may make you dizzy hence do not attempt to drive or operate machinery until you are physically stable and mentally alert. Rompost 500 Combipack Injection 1's should never be used to normalize platelet counts; Rompost 500 Combipack Injection 1's should only be used in ITP patients whose thrombocytopenia and clinical condition increase the risk of bleeding. Rompost 500 Combipack Injection 1's is not recommended for use during breastfeeding.